Tumor Ablation Market Share, Size, Industry Analysis ,2024 - 2032
Tumor Ablation Market Size & Share Global Analysis Report, 2024-2032

Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Feb-2024
  • Pages: 116
  • Format: PDF
  • Report ID: PM1214
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

The global tumor ablation market was valued at USD 1.60 billion in 2023 and is expected to grow at a CAGR of 11.3% during the forecast period.

Tumor ablation is a medical process utilized to treat tumors, which are strange masses of tissue that can develop in numerous parts of the body. Ablation consists the destruction or removal of the tumor. This can be done using different methods, such as cold (cryoablation), heat (radiofrequency ablation), or other energy sources.

Several factors are driving the growth of the tumor ablation market. Cancer's rising prevalence creates a huge demand for effective treatment options. Tumor ablation procedures are a minimally invasive alternative to traditional surgery for treating solid tumors. As cancer rates rise, there is a greater need for treatments that can specifically target and destroy tumors.

  • For instance, according to the Cancer Australia Statistics for the year 2022, Australia witnessed the diagnosis of 162,163 new cases of cancer, with 88,982 affecting males and 73,181 affecting females.

Tumor ablation procedures specifically advantageous for individuals with tumors which cannot be removed by surgery. This contains tumors situated in inaccessible parts in the body, where surgery poses high risks due to the patient's overall health. For such cases, tumor ablation offers a viable treatment alternative, allowing the eradication of tumors without the need for extensive surgical procedures.

Tumor Ablation Market Size
To Understand More About this Research: Request a Free Sample Report

The COVID-19 pandemic has significantly impacted the tumor ablation market. The situation has led to a diversion of healthcare resources and attention towards managing the pandemic, which results in delays in elective procedures, which includes tumor ablation treatments. The focus on acute and crucial healthcare conditions, along with limitations on non-essential medical services, has affected the adoption of tumor ablation technologies.

Further, disruptions in the global supply chain and economic uncertainties have affected healthcare spending and investment decisions, which strongly impacts on the growth of the tumor ablation market. However, as healthcare systems have started to retrieve, the market has rebounded, driven by the increasing prevalence of cancer and the ongoing need for minimally invasive treatment options like tumor ablation.

The research study provides a comprehensive analysis of the industry, assessing the market on the basis of various segments and sub-segments. It sheds light on the competitive landscape and introduces Tumor Ablation Market key players from the perspective of market share, concentration ratio, etc. The study is a vital resource for understanding the growth drivers, opportunities, and challenges in the industry.

Technical advancements to improve accuracy, portability, and cost-effectiveness are the aspects that push market players to continually enhance and launch progressive tumor ablation devices. Cryoablation, Image-guided equipment, and HIFU, are main examples of these technical refinements.

Industry Dynamics

  • Growth Drivers
  • Increasing patients and surgeons’ inclination towards minimally invasive procedures will drive the growth of the market

The increasing leaning of patients and surgeons towards minimally invasive procedures will facilitate the growth of the market. Minimally invasive procedures, as compared to conventional open surgical procedures, need less incisions or a needle insertion. As a result, there is less tissue damage, less blood loss, and a lower risk of complications. These procedures are typically associated with shorter hospital stays and quicker recovery times. Patients are often able to resume routine tasks sooner, which improves their standard of life.

Advanced imaging technologies are frequently used in minimally invasive techniques, allowing surgeons to monitor and accurately target tumors. This enhances accuracy while also preserving healthy surrounding tissues. The surgical instruments are designed to give surgeons additional mobility and agility, allowing them to execute complicated surgeries with greater control and precision. as compared to open surgeries, the procedures use lesser incisions, lowering the risk of post-operative infections.

Report Segmentation

The market is primarily segmented based on technology, mode of treatment, application and region.

By Technology

By Mode of Treatment

By Application

By Region

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Others


  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation


  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Technology Analysis

  • The radiofrequency ablation segment accounted for the largest revenue share in 2022

In 2022, the radiofrequency ablation segment accounted for the largest revenue share. The dominance can be ascribed to its advantages, such as efficiency and specificity in solid tumor ablation techniques in the liver and kidney. As well, radiofrequency ablation are utilized to treat numerous tumors at the same time, therefore enhancing procedural efficiency with the usage of multiple electrodes placed at other sites. This is anticipated to increase the adoption rate of evolved tumor ablation techniques.

On the other hand, the microwave ablation segment is anticipated to witness fastest growth during the forecast period. As compared to a radiofrequency ablation device, the energy an of a microwave (MW) ablation equipment expands electromagnetic fields. This advances the adoption of microwave ablation technology in tissues with a low ability to conduct electricity, such as bones and lungs. Optimal heating of the cystic mass, low ablation pain, consistency in high temperature, and larger tumor ablation volume are all significant benefits of this technology. These advantages are expected to drive the growth.

By Mode of Treatment Analysis

  • The percutaneous ablation segment accounted for the highest market share during the forecast period

The percutaneous ablation segment accounted for the highest market share during the forecast period. These procedures provide a better security, quicker recovery, and less scarring. Additionally, factors like fast surgery time, patient convenience, and cost-efficiency are anticipated to drive the demand in higher number.

Because of unfavorable tumor locations, percutaneous ablations are not attainable in around 25-55% of patients. Percutaneous ablation has a greater tumor recurrence rate. This is owing to inadequate ablation of tumors located deep inside the tissue. Additionally, due to the high risk of recurrence of tumors, percutaneous ablation is not advised for treating the injury that are very close to the bile duct, gall bladder, heart, or gastrointestinal tract.

Regional Insights

  • North America accounted for the largest market share in 2022

In 2022, North America accounted for the largest market share in the tumor ablation market. Increasing rates of cancer, government support for excellent healthcare, higher purchasing power equality, and government backing for premium healthcare are among the main drivers driving the growth of the market in the region.

Rising disposable income, favorable reimbursement structures, and surging demand for minimally invasive cancer treatment procedures. Technical advancements in ablation, increasing ageing population, and the rising number of people who are affected with cancer are also driving the growth of the market in the region.

Asia Pacific is accounted for the fastest growth in the tumor ablation market. The increasing need for minimally invasive tumor ablation techniques and the safe therapeutic choices drive the growth of the market. Also, the initiatives taken by the governments in the more numbers to foster the awareness amidst the people and the growing investments by the private organizations and the governments in Asia Pacific countries is anticipated to drive the growth of the tumor ablation market in the region.

Key Market Players & Competitive Insights

The market is characterized by intense competition, with established players relying on advanced technology, high-quality products, and a strong brand image to drive revenue growth. These companies employ various strategies such as research and development, mergers and acquisitions, and technological innovations to expand their product portfolios and maintain a competitive edge in the market.

Some of the major players operating in the global market include:

  • AngioDynamics Inc.
  • Boston Scientific Corp.
  • BVM Medical Ltd.
  • BTG International Ltd.
  • Integra LifeSciences Holdings Corp.
  • Medtronic plc.
  • Mermaid Medical
  • SonaCare Medical LLC
  • St. Jude Medical Inc.

Recent Developments

  • In April 2023, Compal Electronics has launched a radiofrequency ablation (RFA) system designed for percutaneous and intraoperative coagulation, along with soft tissue ablation. Also, the company has introduced a bilevel ventilator specifically designed for managing chronic obstructive pulmonary disease (COPD) and respiratory insufficiency resulting from central and/or mixed apneas.
  • In March 2023, AngioDynamics has partnered with Minimax Medical to facilitate the global distribution of its array of products. The partnership contains the international distribution of Minimax Medical's advanced Radiofrequency Ablation System, specifically designed for treating tumors and nodules.

Tumor Ablation Market Report Scope

Report Attributes


Market size value in 2024

USD 1.78 billion

Revenue forecast in 2032

USD 4.20 billion


11.3% from 2023 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments Covered

By Technology, By Mode of Treatment, By Application, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation

We provide our clients the option to personalize the Tumor Ablation Market report to suit their needs. By customizing the report, you can get data as per your format and definition. Also, the customization option allows you to gain a deeper dive into a specific segment, region, customer, or market competitor.

Browse Our Top Selling Reports

Abaca Pulp Market Size, Share 2024 Research Report

Healthcare Finance Solutions Market Size, Share 2024 Research Report

Hirsutism Market Size, Share 2024 Research Report

Bring Your Own Device Market Size, Share 2024 Research Report

Luxury Travel Market Size, Share 2024 Research Report


The key companies in Tumor Ablation Market areAngioDynamics Inc., Boston Scientific Corp., BVM Medical Ltd., BTG International Ltd.,

The Tumor Ablation Market expected to grow at a CAGR of 11.3% during the forecast period.

Tumor Ablation Market report covering key segments are technology, mode of treatment, application and region.

North America is leading the global market

The key driving factors in Tumor Ablation Market Increasing prevalence of cancer worldwide will facilitate the growth of the market